David M Bell, MD
Orthopedic Surgery · Pleasanton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 2 carriers
- Offices
- 2
- Since medical school
- 35 years
- Baylor College of Medicine, 1991
Offices
2 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Stanford Health Care Tri-Valley · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
4 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bell’s office at (925) 932-6330 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
4 of 4 plans
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A51438 · Current
Licensed to practise in California · since 1992 · expires 2028-07-31 · Baylor College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Hacienda Outpatient Surgery Center, LLCAmbulatory Surgery Center · Pleasanton, CA5% owner since 2008 · accredited by AAAHCAccreditation Renewed7 inspections, 5 with deficiencies · last 2025-04-03: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Sports Medicine
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$167,347
Medicare paid this office $167,347 for 286 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 76 | $54,010 | None |
| Aspiration and/or injection of fluid from large joint | 150 | $27,170 | $71 |
| Short return visit (20+ min) | 165 | $20,333 | $79 |
| New patient visit (30+ min) | 85 | $7,280 | $86 |
| New patient visit (45+ min) | 46 | $6,033 | $131 |
See all 9 services
| Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 76 | $54,010 | None |
| Aspiration and/or injection of fluid from large joint | 150 | $27,170 | $71 |
| Short return visit (20+ min) | 165 | $20,333 | $79 |
| New patient visit (30+ min) | 85 | $7,280 | $86 |
| New patient visit (45+ min) | 46 | $6,033 | $131 |
| Return visit (30+ min) | 49 | $5,932 | $108 |
| Short return visit | 35 | $2,849 | $54 |
| Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee | 13 | $916 | $70 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $75 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 34 | More than 97% of doctors who do this |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 72 | More than 92% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 336 | 255 | 280 | 297 | 322 | 384 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 19 | 15 | 14 | 12 | 17 | – |
| Repair of shoulder rotator cuff using an endoscope | 18 | – | 14 | 14 | 16 | – |
| Aspiration and/or injection of fluid from medium joint | – | 13 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
286 Original Medicare patients in 2024. Average age 74 · Women 55% · Health risk score 0.75. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 65% · Coronary heart disease 19% · Atrial fibrillation 17% · Diabetes 16% · Cancer 15% · Chronic kidney disease 12% · Depression 9% · Heart failure 6% · COPD 5%.
The office billed $701,872, Medicare allowed $221,047 and paid $167,347; for 9,869 services of 35 kinds; $64,160 of it was for drugs given in the office and $103,187 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 286 | 9,869 | 74 | 0.75 | $701,872 | $167,347 |
| 2023 | 249 | 8,566 | 74 | 0.77 | $990,932 | $197,786 |
| 2022 | 232 | 7,785 | 74 | 0.74 | $867,087 | $188,490 |
| 2021 | 240 | 7,506 | 73 | 0.73 | $769,397 | $176,595 |
| 2020 | 205 | 26,443 | 73 | 0.80 | $628,525 | $132,683 |
| 2019 | 271 | 13,460 | 73 | 0.82 | $640,441 | $134,702 |
| 2018 | 254 | 1,839 | 73 | 0.80 | $521,324 | $101,305 |
| 2017 | 217 | 1,820 | 73 | 0.83 | $404,323 | $85,375 |
| 2016 | 206 | 1,331 | 73 | 0.85 | $351,070 | $69,949 |
| 2015 | 200 | 1,401 | 72 | 0.85 | $354,140 | $93,409 |
| 2014 | 194 | 1,120 | 73 | 0.80 | $246,610 | $81,085 |
| 2013 | 210 | 1,123 | 72 | 0.84 | $143,820 | $80,254 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 45 | $61,053 | None |
| Aspiration and/or injection of fluid from large joint | 114 | $22,181 | $69 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 27 | $22,047 | None |
| Short return visit (20+ min) | 148 | $19,866 | $77 |
| Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg | 27 | $16,039 | None |
| Repair of shoulder rotator cuff using an endoscope | 15 | $15,604 | $975 |
| New patient visit (30+ min) | 92 | $8,569 | $93 |
| Return visit (30+ min) | 49 | $5,962 | $105 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 16 | $2,534 | $149 |
| New patient visit (45+ min) | 16 | $2,440 | $153 |
| Short return visit | 25 | $1,742 | $51 |
| Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee | 12 | $885 | $74 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $36 | None |
2022: 12 services
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 44 | $60,975 | None |
| Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg | 26 | $43,342 | None |
| Aspiration and/or injection of fluid from large joint | 109 | $18,987 | $71 |
| Short return visit (20+ min) | 142 | $17,719 | $74 |
| Repair of shoulder rotator cuff using an endoscope | 14 | $13,187 | $942 |
| New patient visit (30+ min) | 96 | $8,580 | $89 |
| Return visit (30+ min) | 33 | $4,063 | $113 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,806 | $150 |
| New patient visit (45+ min) | 12 | $1,636 | $136 |
| Short return visit | 14 | $943 | $52 |
| Aspiration and/or injection of fluid from large joint | 28 | $582 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 57 | $71 | None |
2021: 10 services
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 49 | $79,930 | None |
| Short return visit (20+ min) | 151 | $21,904 | $80 |
| Aspiration and/or injection of fluid from large joint | 108 | $16,950 | $68 |
| Repair of shoulder rotator cuff using an endoscope | 14 | $13,831 | $988 |
| New patient visit (30+ min) | 106 | $9,493 | $90 |
| Return visit (30+ min) | 35 | $4,132 | $106 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $2,158 | $154 |
| Aspiration and/or injection of fluid from large joint | 29 | $605 | $21 |
| Injection, methylprednisolone acetate, 80 mg | 13 | $119 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $70 | None |
2020: 12 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 35 | $44,615 | None |
| Short return visit (20+ min) | 153 | $16,748 | $59 |
| Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 14 | $15,431 | None |
| Aspiration and/or injection of fluid from large joint | 96 | $13,635 | $60 |
| New patient visit (30+ min) | 72 | $5,767 | $80 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 14 | $2,162 | $144 |
| Short return visit | 39 | $1,878 | $38 |
| Return visit (30+ min) | 13 | $997 | $77 |
| Aspiration and/or injection of fluid from medium joint | 11 | $612 | $47 |
| Aspiration and/or injection of fluid from large joint | 27 | $547 | $20 |
| Injection, methylprednisolone acetate, 80 mg | 20 | $200 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 58 | $155 | None |
2019: 12 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 16 | $20,350 | None |
| Short return visit (20+ min) | 166 | $18,416 | $60 |
| Aspiration and/or injection of fluid from large joint | 129 | $17,513 | $58 |
| Repair of shoulder rotator cuff using an endoscope | 17 | $17,202 | $956 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 47 | $12,238 | None |
| New patient visit (30+ min) | 123 | $11,300 | $92 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 62 | $4,185 | $22 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 18 | $2,923 | $154 |
| Short return visit | 49 | $2,253 | $40 |
| Aspiration and/or injection of fluid from large joint | 33 | $673 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 75 | $302 | None |
| Injection, methylprednisolone acetate, 80 mg | 15 | $145 | None |
2018: 13 services
| Aspiration and/or injection of fluid from large joint | 133 | $17,597 | $58 |
| Short return visit (20+ min) | 166 | $17,403 | $58 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 47 | $15,473 | None |
| Repair of shoulder rotator cuff using an endoscope | 15 | $12,738 | $849 |
| New patient visit (30+ min) | 126 | $10,568 | $84 |
| Removal of knee cartilage using an endoscope | 12 | $4,342 | $362 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $3,480 | $20 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 19 | $2,710 | $143 |
| Short return visit | 35 | $1,607 | $37 |
| Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee | 16 | $1,156 | $72 |
| Aspiration and/or injection of fluid from large joint | 39 | $711 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | $603 | None |
| Injection, methylprednisolone acetate, 80 mg | 22 | $245 | None |
2017: 11 services
| Short return visit (20+ min) | 154 | $16,447 | $59 |
| Aspiration and/or injection of fluid from large joint | 117 | $15,540 | $54 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 50 | $12,828 | None |
| Repair of shoulder rotator cuff using an endoscope | 11 | $9,877 | $898 |
| New patient visit (30+ min) | 107 | $8,832 | $83 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $2,780 | $18 |
| Short return visit | 48 | $2,137 | $37 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,738 | $145 |
| Return visit (30+ min) | 13 | $1,120 | $80 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 81 | $718 | None |
| Aspiration and/or injection of fluid from large joint | 22 | $424 | $19 |
2016: 10 services
| Short return visit (20+ min) | 126 | $12,154 | $58 |
| Aspiration and/or injection of fluid from large joint | 107 | $10,912 | $52 |
| New patient visit (30+ min) | 97 | $7,585 | $78 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 26 | $6,500 | None |
| Return visit (30+ min) | 65 | $6,429 | $81 |
| Removal of both knee cartilages using an endoscope | 11 | $4,293 | $390 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 33 | $1,563 | $18 |
| Short return visit | 17 | $776 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 84 | $562 | None |
| Aspiration and/or injection of fluid from large joint | 25 | $485 | $19 |
2015: 14 services
| Aspiration and/or injection of fluid from large joint | 106 | $12,324 | $56 |
| Return visit (30+ min) | 105 | $11,995 | $84 |
| Repair of shoulder rotator cuff using an endoscope | 12 | $10,933 | $911 |
| Short return visit (20+ min) | 103 | $10,376 | $59 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 33 | $9,672 | None |
| New patient visit (30+ min) | 100 | $8,302 | $83 |
| Removal of both knee cartilages using an endoscope | 12 | $5,154 | $429 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 17 | $2,389 | $141 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $1,996 | $18 |
| X-ray of shoulder, minimum of 2 views | 57 | $1,772 | $26 |
| X-ray of knee, 4 or more views | 38 | $1,396 | $34 |
| Aspiration and/or injection of fluid from large joint | 35 | $688 | $19 |
| X-ray of knee, 3 views | 13 | $456 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 79 | $234 | None |
2014: 13 services
| Short return visit (20+ min) | 112 | $10,474 | $56 |
| Return visit (30+ min) | 82 | $10,449 | $92 |
| Aspiration and/or injection of fluid from large joint | 96 | $8,411 | $52 |
| New patient visit (30+ min) | 93 | $7,692 | $83 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 19 | $4,747 | None |
| X-ray of shoulder, minimum of 2 views | 64 | $2,262 | $29 |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 12 | $1,772 | $148 |
| X-ray of knee, 4 or more views | 32 | $1,459 | $42 |
| Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee | 15 | $1,116 | $74 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $1,000 | $18 |
| Aspiration and/or injection of fluid from large joint | 33 | $722 | $22 |
| X-ray of knee, 3 views | 14 | $647 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 83 | $154 | None |
2013: 11 services
| Short return visit (20+ min) | 167 | $18,895 | $58 |
| Repair of shoulder rotator cuff using an endoscope | 13 | $13,136 | $876 |
| Aspiration and/or injection of fluid from large joint | 109 | $9,024 | $55 |
| New patient visit (30+ min) | 87 | $7,192 | $83 |
| Removal of both knee cartilages using an endoscope | 12 | $5,896 | $491 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 13 | $3,569 | None |
| Shaving of part of shoulder bone and repair of ligament using an endoscope | 17 | $2,497 | $147 |
| X-ray of shoulder, minimum of 2 views | 58 | $1,830 | $27 |
| X-ray of knee, 4 or more views | 33 | $1,403 | $43 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $588 | $18 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 102 | $179 | None |
Drugs they prescribed that Part D paid
$816
Pharmacies billed $816 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 35% of their Part D prescriptions (46 of 133) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
133 generic and 0 brand-name prescriptions · $816 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Meloxicam | 49 | $160 | $3 |
| Oxycodone-Acetaminophen | 31 | $122 | $4 |
| Hydrocodone-Acetaminophen | 11 | $56 | $5 |
Year by year
| 2024 | 133 | 52 | 35% (46) | 0% | $816 |
| 2023 | 123 | 58 | 41% (50) | 0% | $783 |
| 2022 | 107 | 51 | 43% (46) | 0% | $1,075 |
| 2021 | 119 | 50 | 33% (39) | None | $1,193 |
| 2020 | 102 | 45 | 48% (49) | 0% | $1,021 |
| 2019 | 91 | 44 | 56% (51) | 0% | $1,140 |
| 2018 | 110 | 60 | 45% (49) | None | $1,138 |
| 2017 | 87 | 42 | 49% (43) | 0% | $1,048 |
| 2016 | 73 | 37 | 40% (29) | None | $1,168 |
| 2015 | 86 | 43 | 56% (48) | None | $2,283 |
| 2014 | 104 | 45 | 39% (40) | 18% | $15,913 |
| 2013 | 139 | 57 | 48% (67) | None | $2,204 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Ibuprofen | 12 | $197 | $16 |
| Meloxicam | 35 | $163 | $5 |
| Oxycodone-Acetaminophen | 29 | $130 | $4 |
| Hydrocodone-Acetaminophen | 17 | $69 | $4 |
2022: 3 drugs
| Ketorolac Tromethamine | 21 | $338 | $16 |
| Hydrocodone-Acetaminophen | 39 | $195 | $5 |
| Indomethacin | 13 | $116 | $9 |
2021: 4 drugs
| Ketorolac Tromethamine | 16 | $336 | $21 |
| Hydrocodone-Acetaminophen | 33 | $227 | $7 |
| Meloxicam | 22 | $222 | $10 |
| Ibuprofen | 13 | $98 | $8 |
2020: 2 drugs
| Hydrocodone-Acetaminophen | 43 | $256 | $6 |
| Meloxicam | 23 | $90 | $4 |
2019: 3 drugs
| Oxycodone-Acetaminophen | 13 | $278 | $21 |
| Hydrocodone-Acetaminophen | 35 | $233 | $7 |
| Ketorolac Tromethamine | 14 | $224 | $16 |
2018: 3 drugs
| Hydrocodone-Acetaminophen | 44 | $408 | $9 |
| Ketorolac Tromethamine | 15 | $331 | $22 |
| Meloxicam | 11 | $44 | $4 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 31 | $431 | $14 |
| Meloxicam | 25 | $98 | $4 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 14 | $367 | $26 |
| Meloxicam | 11 | $38 | $3 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 28 | $784 | $28 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 19 | $566 | $30 |
| Ketorolac Tromethamine | 13 | $141 | $11 |
| Meloxicam | 11 | $81 | $7 |
2013: 3 drugs
| Hydrocodone-Acetaminophen | 56 | $465 | $8 |
| Ketorolac Tromethamine | 13 | $121 | $9 |
| Meloxicam | 18 | $118 | $7 |
Money from drug and device companies
$588 in 2025
| 2025 | 1 | 3 | None | $588 |
| 2024 | 1 | 1 | None | $94 |
| 2022 | 2 | 20 | None | $3,659 |
| 2021 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vericel | Maci | $588 | 3 payments
|
See all 3 published payments
| Vericel | Meals · 2025-04-12 | Maci | $215 |
| Vericel | Travel · 2025-04-12 | Maci | $184 |
| Vericel | Meals · 2025-04-11 | Maci | $189 |
See earlier years (2024, 2022, 2021)
2024: $94
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $94 | 1 payment
|
2022: $3,659
| Evolution Surgical | None | $2,523 | 6 payments
|
| Arthrex | None | $1,136 | 14 payments
|
2021: $17
| Medtronic | 3f | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619916293
- Licence
- CA A51438California A51438: Current · expires 2028-07-31
- Trained
- Baylor College of Medicine, 1991 · 35 years ago
- Group
- Bass Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 5924 Stoneridge Dr 202, Pleasanton, CA, 94588
- NPI first listed
- 2006-06-06
- NPI last updated
- 2015-12-08
This is when the NPI record was last certified, not a medical board exam.